Sacituzumab govitecan
Sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC) targeting Trop-2, facilitates the delivery of SN-38. It demonstrates anticancer activity .
Product Specifications
CAS Number
1491917-83-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
160 KDa (Approximately)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Antibody-Drug Conjugates (ADCs)
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1094976-01 0.02 mg (E-Coli)
Recombinant Streptococcus equi subsp. zooepidemicus Peptide chain release factor 1 (prfA)
Ask
View Details MBS1094976-02 0.02 mg (Yeast)
Recombinant Streptococcus equi subsp. zooepidemicus Peptide chain release factor 1 (prfA)
Ask
View Details MBS1094976-03 0.1 mg (E-Coli)
Recombinant Streptococcus equi subsp. zooepidemicus Peptide chain release factor 1 (prfA)
Ask
View Details MBS1094976-04 0.1 mg (Yeast)
Recombinant Streptococcus equi subsp. zooepidemicus Peptide chain release factor 1 (prfA)
Ask
View Details